APRE peer analysis
Aprea Therapeutics (APRE) against its competitors: price, today's move, 1-year return and market value side by side.
- APRE's peers: ACXP (Acurx Pharmaceuticals), ADIL (Adial Pharmaceuticals), APVO (Aptevo Therapeutics), BCDA (BioCardia), CELZ (Creative Medical Technology), HCWB (HCW Biologics), INAB (IN8bio), KPRX (Kiora Pharmaceuticals).
APRE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACXP Acurx Pharmaceuticals | $1.03 | 3.00% | -74.25% | $6.24M |
| ADIL Adial Pharmaceuticals | $5.05 | 36.12% | -46.48% | $13.26M |
| APVO Aptevo Therapeutics | $0.41 | -7.20% | -98.12% | $905.14K |
| BCDA BioCardia | $0.77 | 0.08% | -41.47% | $11.70M |
| CELZ Creative Medical Technology | $0.44 | -5.64% | -84.88% | $3.34M |
| HCWB HCW Biologics | $0.74 | -3.77% | -93.87% | $2.31M |
| INAB IN8bio | $0.77 | -0.97% | -52.32% | $8.35M |
| KPRX Kiora Pharmaceuticals | $0.82 | -0.46% | -57.24% | $3.63M |
| RNAZ TransCode Therapeutics | $1.30 | -3.35% | -85.93% | $22.50M |
| APRE Aprea Therapeutics | $0.49 | 6.07% | -58.91% | $7.00M |